These Analysts Cut Their Forecasts On Concentrix Following Q1 Results

robot
Abstract generation in progress

Following its Q1 results, which showed mixed financial performance, Concentrix (NASDAQ: CNXC) has seen several analysts cut their price targets. Despite revenue slightly beating estimates, adjusted EPS missed, and the company issued Q2 guidance below expectations, leading to a 6.9% drop in its share price. Analysts from Baird, Canaccord Genuity, and Barrington Research maintained their ratings but significantly lowered their price targets for Concentrix.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin